Pasteurella and Mannheimia organisms are β-hemolytic, gram-negative, aerobic, nonmotile, nonsporeforming coccobacilli in the family Pasteurellaceae. This family tends to inhabit the mucosal surfaces of the GI, respiratory, and genital tract of mammals. Many are known as opportunistic secondary invaders. Some species show preferences for specific surfaces and hosts. Updating of phylogenetic data has resulted in renaming based on gene sequence analysis. As a result, P haemolytica biotypes A and T were reclassified as M haemolytica (biotype A) and P trehalosi (biotype T). More recently, P trehalosi has been reclassified as Bibersteinia trehalosi. Each isolate of M haemolytica and B trehalosi is designated with a biotype and serotype.
M haemolytica A2 is the most common strain isolated from sheep and goat respiratory pasteurellosis, although A6, A13, and Ant have been reported in sheep and Ant in goats. M haemolytica A2 is routinely reported from cases of mastitis in sheep. B trehalosi T3, T4, T10, and T15 have been most often associated with the systemic or septicemic form of pasteurellosis affecting lambs. These serotypes have been regrouped to B trehalosi biotype 2, and a new biotype 4 has been added. B trehalosi is often isolated from the lungs of sheep, goats, and cattle, but pathogenicity is variable and may be incidental. P multocida has also been reported as a cause of pneumonic pasteurellosis in sheep and goats and has been isolated in herd outbreaks of septic arthritis. M haemolytica is the most commonly isolated bacteria in clinical cases, followed closely by B trehalosi, with P multocida seen less frequently.
Combining the long tradition of vaccine development of Ceva Phylaxia in Hungary and the cutting edge technology of Biomune in USA the company is committed to develop innovative vaccines that can meet the current needs to ensure that health of the animals and people is protected.
COGLAVAX® (Clostridiosis): It is a vaccine that contains 8 different clostridial antigens in one single dose. Clostridial pathogens are ubiquitious and cattle are at risk to be hit by these diseases during most of their lives.
- PASTEROVIS® (pasteurellosis)
PASTEROVIS® is a vaccine for the medical preventions of the primary or secondaries pasteurella infections due to Pasteurella multocida and Pasteurella haemolytica
Features of Pasteurella Vaccine For Sheep And Goats
Santa Cruz Animal Health offers a variety of caprine Pasteurella vaccines for the prevention of disease caused by Pasteurella multocida, Mannheimia haemolytica and Haemophilus somnus in goats. These vaccines are safe for use in all goats including kids, wethers, does and bucks. Choose from top selling products by Colorado Serum. Trust Santa Cruz Animal Health to provide your caprine Pasteurella vaccines.
Symptoms of Pasteurella For Sheep And Goats
- Goats may just be found dead, deaths can occur within 12-24 hours of infection and may occur for further 4-6 weeks
- May cough especially if herded
- Goats may lag behind flock
- Show signs of respiratory distress and lie down
- Fever with evidence of respiratory involvement ( dyspnoea)
- Muco-purulent nasal discharge, lacrimation, froth at mouth
- Some goats may become ‘poor doers’ due to fibrinous adhesions or lung abscess.
Types of vaccine:
The dominant serotypes of Manneheimia haemolytica with pneumonia in sheep have been 6,2,1 (in that order). Mannehaimia haemolytica has also been the one identified in Angora goats when cultured (not typed). Pasteurella multocida is not considered important in Angora goats.
Vaccines licensed for use in goats are:
OBP Pasteurella (OBP)
Ovi-Clos P (Ascendis)
Not licensed for goats (used off label)
One Shot Ultra (Zoetis)
Multivax -P Plus, Multivax-P (MSD)
Prices of Pasteurella Vaccine For Sheep And Goats
$85.90 – $215.00